REQUEST A DEMO
Total
USD $0.00
Search more companies

Skymedic Pharma Colombia S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Skymedic Pharma Colombia S.A.S. Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Skymedic Pharma Colombia S.A.S. is based in Colombia. The head office is in Bogota D.C.. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on January 17, 2022. Skymedic Pharma Colombia S.A.S. currently employs 17 (2026) people. There was a net sales revenue increase of 80.71% reported in Skymedic Pharma Colombia S.A.S.’s latest financial highlights for 2025. Its total assets grew by 74.9% over the same period.

Headquarters
Calle 99 # 11 B - 66
Bogota D.C.; Bogota D.C; Postal Code: 0810

Contact Details: Purchase the Skymedic Pharma Colombia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Skymedic Pharma Colombia S.A.S. report to view the information.
Financial Auditors:
Purchase the Skymedic Pharma Colombia S.A.S. report to view the information.
Incorporation Date:
January 17, 2022
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Skymedic Pharma Colombia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
80.71%
Total Operating Revenue
80.71%
Operating Profit
N/A
Net Profit/Loss for the Period
N/A
Total Assets
74.9%
Total Equity
N/A
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
76.06%
Quick Ratio
0.63%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?